Flow Cytometry Analysis of Patients With MDS
| FAB Subtype . | Patient . | Percentage of T, B, NK Cells in PB-MNC . | Percentage of CD34 Positive Cells and CD34 Positive Subpopulation Cells in BM-MNC . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CD3+ . | CD19+ . | CD3−56+ . | CD34+ . | CD34+7+ . | CD34+19+ . | CD34+33+ . | CD34+Thy1+ . | ||
| RA | 2 | 37.1 | 0.8 | 5.7 | ND | ND | ND | ND | ND |
| 3 | 27.8 | 2.2 | 4.8 | ND | ND | ND | ND | ND | |
| 5 | 78.0 | 0.1 | 10.2 | 1.50 | 0.30 | 0.20 | ND | ND | |
| Mean | 47.6 | 1.0 | 6.9 | 1.50 | 0.30 | 0.20 | |||
| RAEB | 4 | 38.7 | 9.9 | 6.4 | 10.60 | 3.44 | 0.24 | 1.62 | 0.24 |
| CMMoL | 1 | 66.3 | 8.0 | 18.8 | 3.80 | 0.03 | 0.03 | 2.82 | 0.00 |
| RAEB-T | 7 | 3.8 | 2.8 | 1.1 | 10.60 | 2.23 | 0.06 | 1.32 | 0.13 |
| RAEB → AML(M2) | 6 | 1.9 | 0.1 | 0.3 | 18.3 | 0.11 | 0.02 | 0.33 | 0.02 |
| FAB Subtype . | Patient . | Percentage of T, B, NK Cells in PB-MNC . | Percentage of CD34 Positive Cells and CD34 Positive Subpopulation Cells in BM-MNC . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CD3+ . | CD19+ . | CD3−56+ . | CD34+ . | CD34+7+ . | CD34+19+ . | CD34+33+ . | CD34+Thy1+ . | ||
| RA | 2 | 37.1 | 0.8 | 5.7 | ND | ND | ND | ND | ND |
| 3 | 27.8 | 2.2 | 4.8 | ND | ND | ND | ND | ND | |
| 5 | 78.0 | 0.1 | 10.2 | 1.50 | 0.30 | 0.20 | ND | ND | |
| Mean | 47.6 | 1.0 | 6.9 | 1.50 | 0.30 | 0.20 | |||
| RAEB | 4 | 38.7 | 9.9 | 6.4 | 10.60 | 3.44 | 0.24 | 1.62 | 0.24 |
| CMMoL | 1 | 66.3 | 8.0 | 18.8 | 3.80 | 0.03 | 0.03 | 2.82 | 0.00 |
| RAEB-T | 7 | 3.8 | 2.8 | 1.1 | 10.60 | 2.23 | 0.06 | 1.32 | 0.13 |
| RAEB → AML(M2) | 6 | 1.9 | 0.1 | 0.3 | 18.3 | 0.11 | 0.02 | 0.33 | 0.02 |
Abbreviation: ND, not done.